Anti-CD33 Chimeric Antigen Receptor Therapy For Acute Myeloid Leukemia

被引：1
|
作者：
O'Hear, Carol E.
Heiber, Joshua
Geiger, Terrence L.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1441.1441
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1441
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR THERAPY FOR ACUTE MYELOID LEUKEMIA
    O'Hear, Carol
    Heiber, Joshua
    Geiger, Terrence
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S1 - S1
  • [2] Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia
    O'Hear, Carol
    Heiber, Joshua F.
    Schubert, Ingo
    Fey, Georg
    Geiger, Terrence L.
    HAEMATOLOGICA, 2015, 100 (03) : 336 - 344
  • [3] What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
    Joseph G. Jurcic
    Current Hematologic Malignancy Reports, 2012, 7 : 65 - 73
  • [4] What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
    Jurcic, Joseph G.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (01) : 65 - 73
  • [5] Combining Anti-CD33 Chimeric Antigen-Receptor T Cells with the Hypomethylating Agent Decitabine to Treat Acute Myeloid Leukemia
    Ng, Kenneth K. H.
    Del Real, Marissa M.
    Wu, Jonas Jian
    Xue, Tongyuan
    Marcucci, Emanuela
    Yuan, Yate-Ching
    Marcucci, Guido
    Forman, Stephen J.
    Horne, David
    Budde, Lihua E.
    MOLECULAR THERAPY, 2023, 31 (04) : 145 - 146
  • [6] Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia
    Laing, Alison A.
    Harrison, Christine J.
    Gibson, Brenda E. S.
    Keeshan, Karen
    EXPERIMENTAL HEMATOLOGY, 2017, 54 : 40 - 50
  • [7] NK-92 CELLS ENGINEERED WITH ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS (CAR) FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML)
    Rafiq, S.
    Purdon, T. J.
    Schultz, L.
    Klingemann, H.
    Brentjens, R. J.
    CYTOTHERAPY, 2015, 17 (06) : S23 - S23
  • [8] SPECIFIC TARGETING OF ACUTE MYELOID LEUKEMIA BY THE USE OF ENGINEERED CIK (CYTOKINE-INDUCED KILLER) CELLS EXPRESSING THE ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR (CAR)
    Rotiroti, M. C.
    Arcangeli, S.
    Magnani, C. F.
    Cappuzzello, C.
    Biondi, A.
    Tettamanti, S.
    Biagi, E.
    HAEMATOLOGICA, 2017, 102 : 247 - 248
  • [9] Specific Targeting of Acute Myeloid Leukemia by the use of Engineered CIK (Cytokine-Induced Killer) Cells Expressing the Anti-CD33 Chimeric Antigen Receptor (CAR)
    Rotiroti, M. C.
    Arcangeli, S.
    Magnani, C. F.
    Cappuzzello, C.
    Biondi, A.
    Tettamanti, S.
    Biagi, E.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S54 - S55
  • [10] SPECIFIC TARGETING OF ACUTE MYELOID LEUKEMIA BY THE USE OF ENGINEERED CIK (CYTOKINE-INDUCED KILLER) CELLS EXPRESSING THE ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR (CAR)
    Rotiroti, M. C.
    Arcangeli, S.
    Magnani, C. F.
    Cappuzzello, C.
    Biondi, A.
    Tettamanti, S.
    Biagi, E.
    HAEMATOLOGICA, 2016, 101 : S42 - S42
12345